All In Biotech

Free tool

FAERS Monitor: Actemra

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125472 or its brand name (Actemra, Tocilizumab). Reports on generic versions are filed under their own applications.

Reports

115,238

Serious

88,232

77% of reports

Hospitalization

29,733

Death reported

12,708

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective35,679
  • rheumatoid arthritis23,001
  • off label use20,832
  • pain20,416
  • arthralgia17,519
  • joint swelling16,527
  • fatigue15,544
  • rash13,899
  • drug intolerance13,224
  • contraindicated product administered12,254
  • arthropathy11,013
  • alopecia10,836
  • abdominal discomfort10,675
  • synovitis10,657
  • swelling10,597

Reports by year received

View as table
YearReports
200611
20074
20083
200916
2010821
20111,172
20121,880
20132,207
20141,912
20152,597
20164,062
20177,492
20187,920
20199,791
202016,812
202112,742
202212,127
20239,468
202411,141
20258,086
20264,974

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,938,921 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
synovitisSignal10,657261.9254.41,135,429
contraindicated product administeredSignal12,254123.3120.6886,901
rheumatoid arthritisSignal23,00146.145.5813,930
arthropathySignal11,01344.843.9379,542
joint swellingSignal16,52728.828.4384,885
drug intoleranceSignal13,22428.828.3307,546
swellingSignal10,59723.222.7200,283
abdominal discomfortSignal10,67512.312.1104,953
alopeciaSignal10,83610.610.489,849
arthralgiaSignal17,5198.07.9104,589
painSignal20,4166.26.289,463
rashSignal13,8996.05.956,959
drug ineffectiveSignal35,6795.15.0120,310
off label useSignal20,8324.44.456,223
fatigueSignal15,5443.73.631,134

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.